MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Secured Loans History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Secured Loans | ₹2,483 Cr | ₹5,078 Cr | ₹25 Cr | ₹23 Cr | ₹49 Cr |
What is the latest Secured Loans ratio of MANKIND PHARMA ?
| Year | Secured Loans |
|---|---|
| Mar2026 | ₹2,483 Cr |
| Mar2025 | ₹5,078 Cr |
| Mar2024 | ₹25 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹49 Cr |
How is Secured Loans of MANKIND PHARMA Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,483 Cr | -51.11 | |
| Mar2025 | ₹5,078 Cr | 20,317.49 | |
| Mar2024 | ₹25 Cr | 7.44 | |
| Mar2023 | ₹23 Cr | -52.71 | |
| Mar2022 | ₹49 Cr | - | |
Compare Secured Loans of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹101,639.3 Cr | -5.1% | -3.1% | -2.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -5.1% |
-3.1% |
-2.6% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses